Isao_Teshirogi
PDF Upload
About
Us
Ø JPMA
(Japan
Pharmaceu0cal
Manufacturers
Associa0on)
is
a
voluntary
associa0on
comprising
71
research-‐oriented
pharmaceu0cal
companies.
Ø As
a
member
of
the
IFPMA,
JPMA
is
engaged
with
various
global
issues
in
the
pharmaceu0cal
and
healthcare
sector.
Ø JPMA
con0nues
to
act
globally
for
the
advancement
of
medical
treatments
for
pa0ents
worldwide.
1
Our
Interna/onal
Ac/vi/es
“ JPMA’s
Contribu/on
to
Global
Health
”
〔November
9,
2012〕
Ø Par/cipa/on
in
planning
to
“Global
Health
Innova/ve
Technology
Fund（GHIT）” 〔April
,
2013〕
Holding
the
second
“Asia
Partnership
Conference
of
Pharmaceu/cal
Associa/ons
（APAC）”
〔April
11-‐12,
2013〕
Ø Mission
:
“To
expedite
the
launch
of
innova/ve
medicines
for
the
peoples
in
Asia”
2
Contribu/ons
of
the
Pharmaceu/cal
Industry
Contribu0on
to
economic
growth
Creation of
drugs
(Innovation)
Profit
(Return)
R＆D
(Investment)
Contribu/on
cycle
of
Pharmaceu/cal
industry
Contribu0on
to
progress
in
science
and
technology
Contribu0on
to
create
a
healthy
and
safe
society
u Improvement
of
the
level
of
science
and
technology
through
promo/on
of
advanced
research
u Fostering
specialists
who
lead
the
future
advanced
research
u Ripple
effects
on
relevant
industries
u Conquering
diseases
u Extension
of
healthy
life-‐span
u Stable
and
high
level
of
tax
payment
u Offers
jobs
for
many
specialists
in
medicine,
pharmaceu/cal
sciences,
etc.
3
IFPMA
has
developed
points
for
considera/on
on
the
following
topics
Use
of
placebo
in
clinical
trials ―
Principle
32
Use
of
comparators
based
on
differences
in
standard
of
care
and
availability
of
medicines
between
developed,
emerging
and
developing
countries ―
Principles
32
and
35
Conduct
of
clinical
trials
in
vulnerable
pa/ent
popula/ons ―
Principles
9
and
17
Post-‐study
access
to
medical
care
―
Principle
14
4
EOF
hLp://www.jpma.or.jp/english/